ClinicalTrials.gg
Status unknownNCT01731262Updated Nov 21, 2012

Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis

An observational study in Arthritis, Rheumatoid, Neovascularization, Pathologic and Synovitis, sponsored by Third Affiliated Hospital, Sun Yat-Sen University. Status unknown. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-11-21.

Sponsored by Third Affiliated Hospital, Sun Yat-Sen University · Observational

The sponsor has not verified this record recently (last verified Nov 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Enrollment
78
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Rheumatoid arthritis(RA) with a high incidence and high morbidity, the pathogenesis has not been fully elucidated. Fibroblast-like synovial cells excessive proliferation and synovial angiogenesis is the most important cause of RA synovitis and joint destruction. Our study was to find the role of Sonic Hedgehog(SHH) pathway in regulating proliferation of fibroblast-like synovial cells and modulating excess angiogenesis of synovial tissue.

Read the detailed description

4ml blood from active RA patients(n=35) and healthy volunteers (n=35) will be collected

  • peripheral blood mononuclear cells will be detached
  • messenger ribonucleic acid expression of Sonic Hedgehog pathway associated factors in both groups will be detected

Synovial tissues from 4 RA patients and 4 patients with traumatic or meniscal injury who need to carry out knee joint replacement operation will be collected

  • inflammatory feature of synovial tissue will be observed
  • the expression of Shh, Ptch1, Gli1 and Smo in synovial tissue will be detected by immunohistochemistry assay
  • fibroblast-like synoviocytes will be cultured from synovial tissue of RA patients
02

Conditions studied

  • Arthritis, Rheumatoid
  • Neovascularization, Pathologic
  • Synovitis

Keywords

  • Arthritis, Rheumatoid
  • Sonic hedgehog protein, human
  • Neovascularization, Pathologic
  • Synovitis
03

In context

Arthritis, Rheumatoid

3,332 studies on the registry are indexed under Arthritis, Rheumatoid; 443 are open to participants now.

This study's planned enrollment of 78 is below the median of 176 across 1,016 observational studies indexed under Arthritis, Rheumatoid.

Browse Arthritis, Rheumatoid studies →

Lead sponsor

Third Affiliated Hospital, Sun Yat-Sen University is the lead sponsor of 133 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

residents of south China

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • definitely diagnosed
  • the disease is active (DAS28>3.2)

Exclusion criteria

Exclusion Criteria:

  • combined with severe organ dysfunction
  • combined with other rheumatic diseases
05

Study design

Observational model
Case-control
Enrollment
78 participants (estimated)

Groups and cohorts

  • RA group

    expression of Shh pathway associated factors from peripheral blood mononuclear cells or synovial tissues will be detected

  • control group

    expression of Shh pathway associated factors from peripheral blood mononuclear cells or synovial tissues will be detected

06

What researchers measure

Primary outcomes

  1. mRNA expression

    Time frame: 1 day (December 15, 2012)

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2012, a primary completion of Dec 2012 and a completion of Jan 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2012
First posted
Nov 21, 2012
Start
Nov 2012
Primary completionEst.
Dec 2012
CompletionEst.
Jan 2013
Last update
Nov 21, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 21, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01731262
Collaborators
National Natural Science Foundation of China
Responsible party
Shangling Zhu (Post-Graduate, Third Affiliated Hospital, Sun Yat-Sen University) — Principal investigator
First posted
Nov 21, 2012
Start date
Nov 2012
Primary completion
Dec 2012 (estimated)
Completion
Jan 2013 (estimated)
Last update
Nov 21, 2012

Study contacts

Jianlin Huang, PhD
Contact
jianlin_h@163.com
86 02085252194
Guihua Chen, PhD
Contact
zssyyuanzhangban@163.com
86 02085252205
Jianlin Huang, PhD
principal investigator · Third Affiliated Hospital, Sun Yat-Sen University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion